Literature DB >> 8993365

Endogenous vertebrate antibiotics. Defensins, protegrins, and other cysteine-rich antimicrobial peptides.

R I Lehrer1, T Ganz.   

Abstract

Although newly recognized, endogenous cystine-stabilized beta-sheet antimicrobial peptides have ancient origins. These peptides can arm circulating phagocytes and cells of the gastrointestinal, respiratory, and genitourinary tracts to resist invasion by bacteria, mycobacteria, fungi, and enveloped viruses. Defensins and protegrin-like peptides are likely to play a considerable role in innate immunity and may provide molecular templates that can be used to generate novel antibiotics for topical and systemic use.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8993365     DOI: 10.1111/j.1749-6632.1996.tb52963.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  25 in total

1.  Differential expression of caprine beta-defensins in digestive and respiratory tissues.

Authors:  C Zhao; T Nguyen; L Liu; O Shamova; K Brogden; R I Lehrer
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 2.  Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicin.

Authors:  E Andrès
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-01       Impact factor: 3.267

3.  Human beta-defensin 2 and beta-defensin 3 chimeric peptides reveal the structural basis of the pathogen specificity of their parent molecules.

Authors:  Sascha Jung; Justyna Mysliwy; Björn Spudy; Inken Lorenzen; Karina Reiss; Christoph Gelhaus; Rainer Podschun; Matthias Leippe; Joachim Grötzinger
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

Review 4.  [Effector molecules of the innate immune system for treatment of wound infections].

Authors:  L Steinsträsser; S Langer; M Lehnhardt; H U Steinau
Journal:  Chirurg       Date:  2007-04       Impact factor: 0.955

5.  Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides.

Authors:  Slavena Vylkova; Xuewei S Li; Jennifer C Berner; Mira Edgerton
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

6.  Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system.

Authors:  Luis R Martinez; Arturo Casadevall
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

7.  Porcine epithelial beta-defensin 1 is expressed in the dorsal tongue at antimicrobial concentrations.

Authors:  J Shi; G Zhang; H Wu; C Ross; F Blecha; T Ganz
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

8.  Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

Authors:  Lars Steinstraesser; Brian F Tack; Alan J Waring; Teresa Hong; Lee M Boo; Ming-Hui Fan; Daniel I Remick; Grace L Su; Robert I Lehrer; Stewart C Wang
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

9.  Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue.

Authors:  S Krisanaprakornkit; A Weinberg; C N Perez; B A Dale
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls.

Authors:  Richard J Jurevic; Mai Bai; Robert B Chadwick; Theodore C White; Beverly A Dale
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.